The present invention provides the use of muscle-derived myoblasts for the manufacture of a medicament for ameliorating stress urinary incontinence. <;IMAGE>; <;IMAGE>; <;IMAGE>; <;IMAGE>; <;IMAGE>; <;IMAGE>; <;IMAGE>; <;IMAGE>;